Aveanna Healthcare Holdings Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-42.6% vs price
Base Case (Median)
12.8% vs price
Bull Case (75th pct.)
26.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $15.14 | 19.3% | High (40%) |
| PE Comparable | $28.04 | 121.0% | Medium (25%) |
| Graham Number | $5.20 | -59.0% | Medium (40%) |
| EV/EBITDA | $13.49 | 6.3% | Medium (20%) |
| EV/FCF | $16.30 | 28.4% | Medium (20%) |
| Earnings Power Value | $-13.76 | -208.5% | Medium (50%) |
Based on 6 out of 8 methods, AVAH appears fairly valued at the current price of $12.69. The base case fair value of $14.32 implies 12.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.